MVCAX
Price
$31.70
Change
-$0.20 (-0.63%)
Updated
Aug 15 closing price
Net Assets
17.12B
PMDHX
Price
$19.37
Change
-$0.19 (-0.97%)
Updated
Aug 15 closing price
Net Assets
1.61B
Interact to see
Advertisement

MVCAX vs PMDHX

Header iconMVCAX vs PMDHX Comparison
Open Charts MVCAX vs PMDHXBanner chart's image
MFS Mid Cap Value A
Price$31.70
Change-$0.20 (-0.63%)
VolumeN/A
Net Assets17.12B
Principal Small-MidCap Dividend Inc R6
Price$19.37
Change-$0.19 (-0.97%)
VolumeN/A
Net Assets1.61B
MVCAX vs PMDHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MVCAX vs. PMDHX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and PMDHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.1B vs. PMDHX (1.61B). PMDHX pays higher dividends than MVCAX: PMDHX (1.44) vs MVCAX (0.86). MVCAX was incepted earlier than PMDHX: MVCAX (24 years) vs PMDHX (9 years). MVCAX (1.00) is less costly to investors than PMDHX (0.79). PMDHX is a more actively managed with annual turnover of: 37.30 vs. MVCAX (27.00). PMDHX has a lower initial minimum investment than MVCAX: PMDHX (0) vs MVCAX (1000). PMDHX annual gain was more profitable for investors over the last year : 6.03 vs. MVCAX (-3.52). PMDHX return over 5 years is better than : 68.95 vs. MVCAX (47.65).
MVCAXPMDHXMVCAX / PMDHX
Total Expense Ratio0.990.79125%
Annual Report Gross Expense Ratio1.000.79127%
Fund Existence24 years9 years-
Gain YTD3.3255.61759%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.1B1.61B1,064%
Annual Yield % from dividends0.861.4460%
Returns for 1 year-3.526.03-58%
Returns for 3 years6.8116.2542%
Returns for 5 years47.6568.9569%
Returns for 10 years63.09N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTI0.04N/A
+2.30%
Inhibitor Therapeutics Inc.
NTDTY26.950.15
+0.56%
NTT DATA GROUP CORPORATION
VOPKY49.25N/A
N/A
Koninklijke Vopak NV
HLTFF11.45N/A
N/A
HILTON FOOD GROUP PLC
TSPH0.32N/A
N/A
CreateAI Holdings Inc.